Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed director
Inv. presentation
Sorrento Therapeutics, Inc. (SRNE) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/18/2022 8-K Investor presentation
Docs: "Scilex Holding Company Corporate Presentation (March 2022)"
05/21/2019 8-K Investor presentation
Docs: "Scilex Holding Company Corporate Presentation"
04/16/2019 8-K Investor presentation
Docs: "Sorrento CBD Business Presentation"
04/15/2019 8-K Quarterly results
10/28/2015 8-K Investor presentation
Docs: "Sorrento Therapeutics, Inc. Corporate Presentation"
08/17/2015 8-K Investor presentation
Docs: "Sorrento Therapeutics, Inc. Corporate Presentation"
06/03/2015 8-K Investor presentation
Docs: "Sorrento Therapeutics, Inc. Corporate Presentation"
02/09/2015 8-K Investor presentation
Docs: "Sorrento Therapeutics, Inc. Corporate Presentation"
01/12/2015 8-K Investor presentation
Docs: "Sorrento Provides Status Update on the Cynviloq™ Registrational TRIBECA™ Study",
"January 2015 Corporate Presentation of Sorrento Therapeutics, Inc"
10/14/2014 8-K Investor presentation
Docs: "INITIAL PHARMACOKINETIC DATA FROM TRIBECA STUDY SUPPORT POTENTIAL FOR BIOEQUIVALENCE BETWEEN CYNVILOQ AND ALBUMIN-BOUND PACLITAXEL",
":"
06/03/2014 8-K Investor presentation
Docs: "Sorrento Therapeutics, Inc. Corporate Presentation"
03/19/2014 8-K Investor presentation
Docs: "Sorrento Therapeutics, Inc. Corporate Presentation"
11/19/2013 8-K Investor presentation
Docs: "SorrentoTherapeutics, Inc. Corporate Presentation"
10/04/2013 8-K Form 8-K - Current report
06/06/2013 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy